Literature DB >> 19317745

HLA-G polymorphism and in vitro fertilization failure in a Polish population.

O Sipak-Szmigiel1, C Cybulski, D Wokołorczyk, J Lubiński, R Kurzawa, T Baczkowski, M Radwan, P Radwan, E Ronin-Walknowska.   

Abstract

To investigate whether human leukocyte antigen-G (HLA-G) gene polymorphism is associated with in vitro fertilization (IVF) failure, we sequenced exons 2-4 of the HLA-G gene in 50 couples with three or more IVFs (including 10 couples with five or more IVFs) and 58 control fertile couples from a Polish population. Of the 10 different HLA-G alleles identified in our study subjects, neither allele was found to be associated with IVF. We also genotyped 50 couples with IVF and 71 control couples for the -725C>G variant in the promoter region and the 14 bp insertion or deletion polymorphism in the 3' untranslated region of the HLA-G gene. The frequency of -725GG or GC genotype in women with IVF and in control fertile women was similar [26% vs 25.3%; odds ratio (OR) = 1.0; P = 1.0]. The 14 bp ins/ins or ins/del genotype was more common in women with IVF than in control women (76.9% vs 59.1%; OR 2.4; P = 0.03), but the difference was not significant after Bonferroni correction for multiple comparisons. The frequency of the ins/ins or ins/del genotype was particularly high (90%) in women who experienced five or more IVFs (OR = 6.2; P = 0.08), but again, the excess was not statistically significant, possibly because of small sample sizes. These results are in line with functional studies that show lower levels of HLA-G mRNA and protein related to the HLA-G allele including the 14 bp sequence and suggest that the insertion allele may be associated with an increased risk of IVF.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19317745     DOI: 10.1111/j.1399-0039.2008.01205.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  7 in total

Review 1.  The HLA-G 14-bp polymorphism and recurrent implantation failure: a meta-analysis.

Authors:  Wei Fan; Zhongying Huang; Shangwei Li; Zhun Xiao
Journal:  J Assist Reprod Genet       Date:  2017-07-13       Impact factor: 3.412

Review 2.  HLA class Ib in pregnancy and pregnancy-related disorders.

Authors:  Gry Persson; Wenna Nascimento Melsted; Line Lynge Nilsson; Thomas Vauvert F Hviid
Journal:  Immunogenetics       Date:  2017-07-11       Impact factor: 2.846

3.  HLA-G polymorphisms and soluble HLA-G protein levels in women with recurrent pregnancy loss from Basrah province in Iraq.

Authors:  Raghed M Jassem; Wafaa Sadoon Shani; Dagan A Loisel; Maysoon Sharief; Christine Billstrand; Carole Ober
Journal:  Hum Immunol       Date:  2012-05-28       Impact factor: 2.850

Review 4.  Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association.

Authors:  Eduardo A Donadi; Erick C Castelli; Antonio Arnaiz-Villena; Michel Roger; Diego Rey; Philippe Moreau
Journal:  Cell Mol Life Sci       Date:  2010-11-24       Impact factor: 9.261

5.  Association of the maternal 14-bp insertion/deletion polymorphism in the histocompatibility leukocyte antigen G gene with recurrent implantation failure.

Authors:  Mahbubeh Enghelabifar; Somaiieh Allafan; Jina Khayatzadeh; Khadijeh Shahrokh Abadi; Mohammad Hasanzadeh Nazarabadi; Fahimeh Moradi; Nozhat Musavifar; Mohsen Jalali; Majid Mojarrad
Journal:  Iran J Reprod Med       Date:  2014-09

6.  Insights into HLA-G Genetics Provided by Worldwide Haplotype Diversity.

Authors:  Erick C Castelli; Jaqueline Ramalho; Iane O P Porto; Thálitta H A Lima; Leandro P Felício; Audrey Sabbagh; Eduardo A Donadi; Celso T Mendes-Junior
Journal:  Front Immunol       Date:  2014-10-06       Impact factor: 7.561

Review 7.  KIR, LILRB and their Ligands' Genes as Potential Biomarkers in Recurrent Implantation Failure.

Authors:  Izabela Nowak; Karolina Wilczyńska; Jacek R Wilczyński; Andrzej Malinowski; Paweł Radwan; Michał Radwan; Piotr Kuśnierczyk
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2017-05-18       Impact factor: 4.291

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.